Chung-Yi Liu
Overview
Explore the profile of Chung-Yi Liu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
66
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Chen M, Chang Y, Sheng T, Huang L, Kan H, Liu C, et al.
Ther Clin Risk Manag
. 2024 Dec;
20:883-892.
PMID: 39726732
Background: Evaluating risk factors for bleeding events in robot-assisted partial nephrectomy (RAPN) for renal angiomyolipoma (RAML) is essential for improving surgical outcomes. Methods: We performed a retrospective analysis of patients...
2.
Chen P, Chang R, Wang H, Chang Y, Liu C, Huang L, et al.
Clin Interv Aging
. 2024 Dec;
19:2071-2083.
PMID: 39678145
Objective: To investigate the impact of body mass index (BMI) on preoperative characteristics, lower urinary tract symptoms (LUTS), intraoperative variables, surgical outcomes and postoperative complications. Methods: This is a retrospective...
3.
Shao I, Chen S, Chen H, Sheng T, Chang Y, Liu C, et al.
BMC Cancer
. 2024 Nov;
24(1):1344.
PMID: 39482661
Purpose: This study aimed to develop a novel model that combines both clinical and image-based parameters to predict early recovery of urinary incontinence after robotic-assisted radical prostatectomy (RARP) more easily...
4.
Fan L, Li Y, Wu C, Chuang K, Li W, Liu C, et al.
J Clin Med
. 2024 Feb;
13(3).
PMID: 38337466
Bladder cancer is a common urinary tract malignancy. Minimally invasive radical cystectomy has shown oncological outcomes comparable to the conventional open surgery and with advantages over the open procedure. However,...
5.
Yu K, Chen S, Lin P, Liu C, Joon A, Yang Y, et al.
Ann Surg Oncol
. 2023 Jun;
30(8):5286-5294.
PMID: 37291441
Background: Lymph node invasion is associated with poor outcome in patients with renal cell carcinoma (RCC). Patients And Methods: Patients with RCC within a single center from 2001 to 2018...
6.
Lin P, Hung W, Chang Y, Hsieh M, Liu C, Huang L, et al.
Cancers (Basel)
. 2023 Feb;
15(4).
PMID: 36831686
Background: To evaluate the efficacy of intravesical chemotherapy replacement in patients with intermediate- and high-risk non-muscle-invasive bladder cancer (NMIBC), who underwent bacillus Calmette-Guérin (BCG) instillation but discontinued due to global...
7.
Liu C, Chang T, Hsieh C, Chang Y, Pang J, Chuang C
Anticancer Res
. 2022 Oct;
42(10):4753-4762.
PMID: 36191984
Background/aim: The transcription factor Kruppel-like factor 2 (KLF2) is thought to act as a tumor suppressor. However, its expression and function in renal angiomyolipomas (AMLs) remains unclear. This study aimed...
8.
Lee C, Chang Y, Liu C, Hsieh M, Huang L, Chu Y, et al.
Investig Clin Urol
. 2022 Sep;
63(5):546-553.
PMID: 36068000
Purpose: Metastatic castration-resistant prostate cancer (mCRPC) has a poor prognosis. Abiraterone acetate (AA), enzalutamide, and chemotherapy are first-line treatments for patients with mCRPC. This study examined prognostic factors for AA...
9.
Liu C, Su S, Chang T, Hsieh M, Chang Y, Pang J, et al.
World J Oncol
. 2022 Jul;
13(3):107-116.
PMID: 35837323
Background: Clooxygenase-2 (COX-2) expression is overexpressed in human prostate cancer, and aberrant methylation of the promoter has also been elucidated. However, how the methylation of CpG islands at regulates its...
10.
Yang Y, Hsieh M, Chen S, Liu C, Lin P, Kan H, et al.
Cancers (Basel)
. 2022 Jun;
14(12).
PMID: 35740695
Background: To compare the intraoperative and postoperative outcomes of indocyanine green (ICG) administration in robot-assisted partial nephrectomy (RAPN) and report the differences in the results between patients with benign and...